A new multi-epitope vaccine candidate based on S and M proteins is effective in inducing humoral and cellular immune responses against SARS-CoV-2 variants: an in silico design approach.

bebtelovimab (LY-CoV1404) - AbCellera, Eli Lilly

http://www.ncbi.nlm.nih.gov/pubmed/37874075

Amir Samimi Hashjin; Hamid Madanchi; Khadijeh Ahmadi; Mosayeb Rostamian; Souroush Sardari; Vahid Khalaj

Oct 25, 2023